These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38456332)

  • 1. Identification of Potential Inhibitors of the SARS-CoV-2 NSP13 Helicase via Structure-Based Ligand Design, Molecular Docking and Nonequilibrium Alchemical Simulations.
    Di Paco G; Macchiagodena M; Procacci P
    ChemMedChem; 2024 May; 19(10):e202400095. PubMed ID: 38456332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computer-aided Design of Wide-spectrum Coronavirus Helicase NSP13 Cage Inhibitors: A Molecular Modelling Approach.
    Shiryaev V; Klimochkin Y
    Curr Comput Aided Drug Des; 2024; 20(7):1027-1041. PubMed ID: 37921184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase.
    Freidel MR; Armen RS
    PLoS One; 2021; 16(2):e0246181. PubMed ID: 33596235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme.
    Ahmad S; Waheed Y; Ismail S; Bhatti S; Abbasi SW; Muhammad K
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase.
    Newman JA; Douangamath A; Yadzani S; Yosaatmadja Y; Aimon A; Brandão-Neto J; Dunnett L; Gorrie-Stone T; Skyner R; Fearon D; Schapira M; von Delft F; Gileadi O
    Nat Commun; 2021 Aug; 12(1):4848. PubMed ID: 34381037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays.
    Inniss NL; Rzhetskaya M; Ling-Hu T; Lorenzo-Redondo R; Bachta KE; Satchell KJF; Hultquist JF
    SLAS Discov; 2024 Apr; 29(3):100145. PubMed ID: 38301954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Repurposed Drug Interferes with Nucleic Acid to Inhibit the Dual Activities of Coronavirus Nsp13.
    Soper N; Yardumian I; Chen E; Yang C; Ciervo S; Oom AL; Desvignes L; Mulligan MJ; Zhang Y; Lupoli TJ
    ACS Chem Biol; 2024 Jul; 19(7):1593-1603. PubMed ID: 38980755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity.
    Mohammad TSH; Gupta Y; Reidl CT; Nicolaescu V; Gula H; Durvasula R; Kempaiah P; Becker DP
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13).
    Ugurel OM; Mutlu O; Sariyer E; Kocer S; Ugurel E; Inci TG; Ata O; Turgut-Balik D
    Int J Biol Macromol; 2020 Nov; 163():1687-1696. PubMed ID: 32980406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-stage structure-based virtual screening approach towards identification of potential SARS-CoV-2 NSP13 helicase inhibitors.
    El Hassab MA; Eldehna WM; Al-Rashood ST; Alharbi A; Eskandrani RO; Alkahtani HM; Elkaeed EB; Abou-Seri SM
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):563-572. PubMed ID: 35012384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of COVID-19 Inhibitors Targeting the SARS-CoV-2 Nsp13 Helicase.
    White MA; Lin W; Cheng X
    J Phys Chem Lett; 2020 Nov; 11(21):9144-9151. PubMed ID: 33052685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors.
    Yazdi AK; Pakarian P; Perveen S; Hajian T; Santhakumar V; Bolotokova A; Li F; Vedadi M
    ACS Infect Dis; 2022 Aug; 8(8):1533-1542. PubMed ID: 35822715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High throughput screening for SARS-CoV-2 helicase inhibitors.
    Otsuka Y; Kim E; Krueger A; Shumate J; Wang C; Bdiri B; Ullah S; Park H; Scampavia L; Bannister TD; Chung D; Spicer TP
    SLAS Discov; 2024 Sep; 29(6):100180. PubMed ID: 39173831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
    Habtemariam S; Nabavi SF; Banach M; Berindan-Neagoe I; Sarkar K; Sil PC; Nabavi SM
    Arch Med Res; 2020 Oct; 51(7):733-735. PubMed ID: 32536457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A structural-based virtual screening and
    Ibrahim IM; Elfiky AA; Mahmoud SH; ElHefnawi M
    J Biomol Struct Dyn; 2024 Oct; 42(17):9145-9158. PubMed ID: 37615430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Fluorescent Assay and Imidazole-Containing Inhibitors by Targeting SARS-CoV-2 Nsp13 Helicase.
    Zhang C; Yu J; Deng M; Zhang Q; Jin F; Chen L; Li Y; He B
    Molecules; 2024 May; 29(10):. PubMed ID: 38792162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.
    Zeng J; Weissmann F; Bertolin AP; Posse V; Canal B; Ulferts R; Wu M; Harvey R; Hussain S; Milligan JC; Roustan C; Borg A; McCoy L; Drury LS; Kjaer S; McCauley J; Howell M; Beale R; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2405-2423. PubMed ID: 34198322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential phytochemical inhibitors of SARS-CoV-2 helicase Nsp13: a molecular docking and dynamic simulation study.
    Vivek-Ananth RP; Krishnaswamy S; Samal A
    Mol Divers; 2022 Feb; 26(1):429-442. PubMed ID: 34117992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach.
    Romeo I; Ambrosio FA; Costa G; Corona A; Alkhatib M; Salpini R; Lemme S; Vergni D; Svicher V; Santoro MM; Tramontano E; Ceccherini-Silberstein F; Artese A; Alcaro S
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase.
    Abidi SH; Almansour NM; Amerzhanov D; Allemailem KS; Rafaqat W; Ibrahim MAA; la Fleur P; Lukac M; Ali S
    Sci Rep; 2021 May; 11(1):10290. PubMed ID: 33986405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.